Skip to main content
. 2015 Oct 30;7(4):471–485. doi: 10.3390/pharmaceutics7040471

Figure 9.

Figure 9

(a) Comparison of amount of BSA coated on to the plasma and untreated PEEK and PC microneedles and residual BSA from the needle after insertion; (b) comparative permeation profiles of BSA across neonatal porcine skin when released from untreated and plasma treated MN (PEEK). Means (±SD), n ˃ 3.